Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
In order to assess the efficacy of hydroxychloroquine treatment weekly for a total of 7 weeks
in the prevention of COVID-19 infection, three hundred sixty (360) Healthcare workers with
high risk exposure to patients infected with COVID-19 will be tested for COVID-19 infection
via nasopharyngeal (NP) swab once weekly for 7 weeks. Of those, one hundred eighty (180) will
receive weekly doses of hydroxychloroquine for the duration of the study. Subjects who opt
not to receive the study drug will form the control group.